A recording of this presentation is available HERE.
Thanks to Dr. Ray Mak for a good refresher on menstrual suppression. A reminder from Dr. Mak up front that there are varied reasons that people with a uterus prefer to suppress their menstruation -- from personal preference to medical indications, and we can and should know how to counsel them on how to safely do so.
Check out this table that outlines some of the reasons for menstrual suppression. Not included in the table are financial reasons (people spend $6000-$18,000 over their lifetime for menstrual products) or cancer risk reduction.
Patient preference | Challenges with menstrual hygiene | Intellectual or developmental delay Limited dexterity or mobility | |
Gynecologic | Dysmenorrhea Endometriosis-related pain and bleeding Menorrhagia PMS Abnormal uterine bleeding | Work or social indications | Military deployment or space travel Athletes Camping or wilderness experience |
Hematologic | Anemia Coagulation disorder Malignancy Chemotherapy | Other conditions worsened by menses | Irritable bowel syndrome Asthma Postural tachycardia syndrome Migraines |
- vaginal ring (skipping ring-free week)>> amenorrhea 89% at 6 months, BTB more common early and diminishes with time (NSAIDs may help, no studies on adding estrogen)
- contraceptive patch (skipping patch-free week), not as well studied, no long term data, higher estrogen exposure, similar issues with BTB
- hormonal IUD (Mirena, Liletta)>> amenorrhea 50% at 1 year, 60% at 5 years; lower dose IUD not effective at attaining amenorrhea, can uses NSAID/estrogen or OCPs for BTB
- depo provera injections>> amenorrhea 50-75% at 1 year, increases with prolonged use; concerns about decreased bone density over time, also weight gain/mood changes. For BTB: NSAID, estrogen, cOCPs, decreasing injection interval (e.g. 2 months)
- etonogestrel implant>> 22% amenorrhea at 1 year, improved with prolonged use, irregular BTB is common
- norethindrone acetate 5mg daily, not approved for contraception>> 76% amenorrhea at 2 years, can titrate up to 15mg daily (for BTB), different than norethindrone mini-pill (0.35)
- testosterone therapy for trans and gender diverse patients >> testosterone therapy usually suppresses by 3-6 months, transmen generally prefer to avoid estrogen (because of desire for masculinization)
- GnRH agonists (puberty blockers), fast onset 4-6 weeks, high efficacy 96%, no increased prothrombotic use (often used in oncologic patients)
- Danazol
- can they swallow pills?
- can they tolerate invasive procedure?
- caution: bone density, weight gain, VTE risk in pts with decrease mobility at baseline
- scheduled withdrawal bleeding may be preferred over random BTB
No comments:
Post a Comment